Atlas Trials

COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC

Clinical trial NCT02484664 · COMPLETED

Trial details

NCT number
NCT02484664
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphangioleiomyomatosis (LAM)
Start date
2016-06-15
Primary completion
2018-11-19
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.